Clinical Strategies in the Management of Diabetic Retinopathy: A step-by-step Guide for Ophthalmologists
Editat de Francesco Bandello, Marco Attilio Zarbin, Rosangela Lattanzio, Ilaria Zucchiattien Limba Engleză Hardback – 13 mai 2014
| Toate formatele și edițiile | Preț | Express |
|---|---|---|
| Paperback (2) | 351.23 lei 38-44 zile | |
| Springer Berlin, Heidelberg – oct 2016 | 351.23 lei 38-44 zile | |
| Springer International Publishing – 14 feb 2019 | 384.92 lei 38-44 zile | |
| Hardback (2) | 424.74 lei 22-36 zile | |
| Springer – 13 mai 2014 | 424.74 lei 22-36 zile | |
| Springer International Publishing – 28 sep 2018 | 549.33 lei 38-44 zile |
Preț: 424.74 lei
Preț vechi: 447.09 lei
-5% Nou
Puncte Express: 637
Preț estimativ în valută:
81.29€ • 84.44$ • 67.52£
81.29€ • 84.44$ • 67.52£
Carte disponibilă
Livrare economică 13-27 ianuarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9783642545023
ISBN-10: 3642545025
Pagini: 178
Dimensiuni: 155 x 235 x 14 mm
Greutate: 0.46 kg
Ediția:2014
Editura: Springer
Colecția Springer
Locul publicării:Berlin, Heidelberg, Germany
ISBN-10: 3642545025
Pagini: 178
Dimensiuni: 155 x 235 x 14 mm
Greutate: 0.46 kg
Ediția:2014
Editura: Springer
Colecția Springer
Locul publicării:Berlin, Heidelberg, Germany
V-ar putea interesa
-
Handbook of Pediatric Strabismus and AmblyopiaKenneth W. Wright-5%Preț: 1265.93 lei1332.57 lei -
Review Questions in OphthalmologyKenneth C. Chern-19%Preț: 899.37 lei1107.40 lei -
Hydroxychloroquine and Chloroquine RetinopathyDavid J. Browning-70%Preț: 159.87 lei532.91 lei -
Recent Advances in Eye ResearchAdelle Hogarth-27%Preț: 1344.97 lei1849.45 lei -
-5%Preț: 664.76 lei699.74 lei -
Ocular Vascular Occlusive DisordersSohan Singh Hayreh-5%Preț: 1565.45 lei1647.84 lei -
Intravitreal SteroidsAlbert J. Augustin-5%Preț: 701.80 lei738.74 lei -
Management of Complicated Vitreoretinal DiseasesFabio Patelli-5%Preț: 665.71 lei700.75 lei -
-5%Preț: 831.68 lei875.46 lei -
Teleophthalmology in Preventive MedicineGeorg Michelson-5%Preț: 702.87 lei739.86 lei -
Augenheilkunde: für Studium, Praktikum und PraxisHeinrich Freyler-5%Preț: 552.65 lei581.73 lei
Public țintă
Professional/practitionerTextul de pe ultima copertă
Diabetic
retinopathy
(DR)
and
its
dramatic
and
sight-threatening
complications,
such
as
diabetic
macular
edema,
remain
a
leading
cause
of
visual
impairment
among
the
working-age
population.
With
the
advent
of
effective
treatments,
a
new
era
in
the
management
of
DR
has
been
opened
up:
it
is
now
possible
for
patients
to
regain
a
degree
of
visual
acuity
not
previously
expected.
However,
amid
the
deluge
of
approved
treatments
and
promising
new
strategies,
clinicians
may
find
it
difficult
to
choose
the
appropriate
practice
in
each
individual
case.
The purpose of this easy-to-use and richly illustrated manual is to assist ophthalmologists in making decisions in the entire management of DR based on the best available evidence. Practical and complete recommendations are provided to guide clinicians in diagnosis, decision-making, and treatment. The manual includes practical algorithms and case histories relating to all stages of DR that clearly explain the progression of the disease and will help the clinician to choose the best therapeutic approach. It will be an ideal resource for ophthalmologists aiming to provide optimal clinical management for this sight-threatening disease.
The purpose of this easy-to-use and richly illustrated manual is to assist ophthalmologists in making decisions in the entire management of DR based on the best available evidence. Practical and complete recommendations are provided to guide clinicians in diagnosis, decision-making, and treatment. The manual includes practical algorithms and case histories relating to all stages of DR that clearly explain the progression of the disease and will help the clinician to choose the best therapeutic approach. It will be an ideal resource for ophthalmologists aiming to provide optimal clinical management for this sight-threatening disease.
Caracteristici
Practical
guide
summarizing
evidence-based
recommendations
to
support
clinical
decisions
Treatment algorithms that will assist in quick point of care choices
Well-illustrated case studies to help in optimal management of the different stages of the disease
Treatment algorithms that will assist in quick point of care choices
Well-illustrated case studies to help in optimal management of the different stages of the disease
Cuprins
Chapter 1. Epidemiology, Risk Factors, and Pathophysiology of Diabetic Retinopathy.- Chapter 2. Non-proliferative Diabetic Retinopathy.- Chapter 3. Diabetic Macular Edema.- Chapter 4. Proliferative Diabetic Retinopathy.- Chapter 5. Proliferative Diabetic Retinopathy: Treatment Update.- Chapter 6. Advanced Proliferative Diabetic Retinopathy.
Recenzii
“It is a practical and informative text intended to guide the clinician in day-today decision-making. … This book is intended for ophthalmology residents, medical and surgical retina fellows, and general ophthalmologists who treat DR and DME.” (EuroTimes, March, 2017)
Notă biografică
Francesco Bandello, MD, FEBO is Professor and Chairman of the Department of Ophthalmology, University Vita-Salute, Scientific Institute San Raffaele, Milan, Italy. He serves as Academic Dean at his University. He is President of Euretina, Vice President of Academia Ophthalmologica Europea, Fellow of the European Leadership Development Programme of the American Academy of Ophthalmology and a former Executive Committee Member of The Macula Society and of the Club Jules Gonin. Dr. Bandello is Associate Editor of the European Journal of Ophthalmology and Editor of Developments in Ophthalmology (Karger, Basel). Dr. Bandello is also an editorial board member of several other journals, including JAMA Ophthalmology, Case Reports in Ophthalmology, Journal of Ocular Pharmacology and Therapeutics and Ophthalmologica. He has been principal investigator in several clinical trials mainly focusing on age-related macular degeneration and diabetic retinopathy. Dr. Bandello has published 220 articles in peer-reviewed journals and is the co-author of seven books.
Marco Attilio Zarbin, MD, PhD, FACS was appointed chair of the Institute of Ophthalmology and Visual Science, New Jersey Medical School and chief of ophthalmology at University Hospital in Newark, N.J., in 1994. He is a professor of ophthalmology and neuroscienceat the New Jersey Medical School and holds the Alfonse A. Cinotti,MD/Lions Eye Research Chair in the Department of Ophthalmology. Dr. Zarbin is also co-director of the Ocular Cell Transplantation Laboratory and the co-director of the Center for Macular Degeneration Research at UMDNJ. His research is focused on developing new surgical treatments for age-related macular degeneration, the leading cause of blindness in persons over age 55 in the United States and Western Europe. He is the editor-in-chief of Translational Vision Science and Technology, and has served as associate editor of Investigative Ophthalmology and Visual Science and as a member of the editorial board of Survey of Ophthalmology. Dr. Zarbin is a vice chair of the Scientific Advisory Board of the Foundation Fighting Blindness and is an ex officio member of the board of Governors of the New Jersey Academy of Ophthalmology and the National Advisory Eye Council of the National Institutes of Health. In addition, he is a member of the American Ophthalmological Society, the Retina Society, the Macula Society and the Vitreous Society and is past president of the board of trustees of the Association of University Professors of Ophthalmology (AUPO) and has served as the alternate AUPO representative to the Council of the American Academy of Ophthalmology. Dr. Zarbin has been listed among the "Best Doctors in America," as well as among the "Best Doctors in New Jersey" and the "Best Doctors in New York."
Ilaria Zucchiatti, MD is currently a Consultant at the Department of Ophthalmology, University Vita-Salute, Scientific Institute San Raffaele, Milan, Italy, having previously completed her specialization in ophthalmology. Her specific research interest involves age related macular degeneration and diabetic retinopathy. She has been Study Coordinator for various randomized clinical trials relating to retinal diseases. Dr. Zucchiatti has to date authored sixteen articles in peer-reviewed journals.
Rosangela Lattanzio, MD is a member of the Department of Ophthalmology, University Vita-Salute, Scientific Institute San Raffaele, Milan, Italy and Head of the Medical Retina Service-Vasculopathies at San Raffaele Hospital. Since 2002 she has been an Editorial Associate of the European Journal of Ophthalmology. From 2008 to 2010, Dr. Lattanzio served on the Scientific Committee of the Italian Society of Ophthalmology. Her particular research interest is the retina (vasculopathies, diabetic retinopathy, retinal vein occlusions, etc.). She was awarded in 2004 Kreissig award-Euretina and in 2007 First Prize by the Italian Society of Ophthalmology for a research project. Dr. Lattanzio is an elected member of the Club Jules Gonin. She has been principal investigator or study coordinator in several clinical trials mainly focusing on retinal vasculopathies. Dr. Lattanzio is the author of numerous articles in peer-reviewed journals and is the co-author of one book.